Inicio › Enfermedad de Alzheimer › Nueva Jersey
Ensayos clínicos de Enfermedad de Alzheimer en Nueva Jersey
25 estudios sobre Enfermedad de Alzheimer buscan participantes en Nueva Jersey.
Ciudades en Nueva Jersey
Texto oficial del estudio (inglés)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 30 sept 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Bio Behavioral Health, Toms River
ReclutandoFase 2
Edades de 55 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1664, Princeton
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06937229A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- The Cognitive and Research Center of New Jersey - Springfield- Site Number : 8400005, Springfield
ReclutandoFase 2
Edades de 55 a 85 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07688213A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Advanced Memory Research Institute - CenExel - PPDS, Toms River
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- CenExel Research - Toms River, Toms River
ReclutandoFase 2
Edades de 55 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- The Cognitive and Research Center of New Jersey, Ridgewood
- The Cognitive and Research Center of New Jersey, Springfield
ReclutandoFase 3
Edades de 50 a 90 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07177352Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
- Kessler Foundation, East Hanover
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05048966A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- The Cognitive and Research Center of New Jersey, Springfield
- Advanced Clinical Institute, West Long Branch
ReclutandoFase 3
Edades de 60 a 85 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06976203Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
- Hackensack Medical Center, Hackensack
Reclutando
Edades de 50 a 100 · Todos los sexos · Actualizado el 17 sept 2026 · NCT05295615A Postmarketing Study of Lecanemab for the Treatment of Participants With Alzheimer's Disease
- Eisai Trial Site #1, Nutley
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 16 sept 2026 · NCT07821658A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Global Medical Institutes LLC; Princeton Medical Institute, Princeton
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2650, Toms River
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0059, Livingston
- Local Institution - 0081, Toms River
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- The Cognitive and Research Center of New Jersey - Ridgewood ( Site 1064), Ridgewood
- The Cognitive and Research Center of NJ ( Site 1057), Springfield
- CenExel- AMRI ( Site 1018), Toms River
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 26 ago 2026 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
ReclutandoFase 1
Edades de 50 a 85 · Todos los sexos · Actualizado el 24 ago 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Advanced Memory Research Institute of New Jersey, Toms River
ReclutandoFase 3
Edades de 60 a 85 · Todos los sexos · Actualizado el 20 ago 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Rutgers-Robert Wood Johnson Medical School, New Brunswick
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06563895A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- The Cognitive and Research Center of New Jersey, Springfield
ReclutandoFase 3
Edades de 55 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- CenExel-HRI, Marlton
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 45 a 85 · Todos los sexos · Actualizado el 4 jun 2026 · NCT06657768A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
- Eisai Trial Site #1, Nutley
ReclutandoEstudio observacional
Edades de 19 en adelante · Todos los sexos · Actualizado el 21 abr 2026 · NCT06810960Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- Nuclear Imaging Institute, Englewood
ReclutandoFase 2Se aceptan voluntarios sanos
Edades de 18 a 120 · Todos los sexos · Actualizado el 13 abr 2026 · NCT07012993Exercise to Improve Brain Health in Older African Americans
- Rutgers, The State University of New Jersey - Newark campus, Newark
ReclutandoFase 2Se aceptan voluntarios sanos
Edades de 60 en adelante · Todos los sexos · Actualizado el 20 feb 2026 · NCT05597124ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
- Rutgers - Institute for Health, New Brunswick
ReclutandoFase 2Se aceptan voluntarios sanos
Edades de 60 en adelante · Todos los sexos · Actualizado el 6 feb 2026 · NCT07392723Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 2 feb 2026 · NCT07105709De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.